| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $356K | -40.6% |
| SG&A Expense | $1.7M | -9.6% |
| Operating Income | -$2.0M | +17.3% |
| Interest Expense | $32K | -20.2% |
| Income Tax | $0 | — |
| Net Income | -$2.0M | +23.7% |
| EPS (Diluted) | -$0.01 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Inventory | $0 | -100.0% |
| Current Assets | $192K | +26.3% |
| Total Assets | $270K | -5.2% |
| Current Liabilities | $1.6M | -15.9% |
| Total Liabilities | $2.7M | +35.8% |
| Stockholders' Equity | -$2.4M | -42.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +45.7% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $1.3M | -44.5% |